The United States surpassed 170,000 coronavirus deaths, according to a Reuters tally, as health officials express concerns over Covid-19 complicating the fall flu season.

The U.S. death toll from Covid-19 fell 16% to about 7,200 people last week, the first decline in deaths after four weeks of increases, according to a Reuters tally of state and county reports.

The medical cannabis market in the United States, even with all of its restrictions, continues to be a fertile area not only for dispensaries, but pharma companies developing cannabis-derived drugs; and proponents say further growth can be generated by educating physicians about medical cannabis.

U.S. coronavirus deaths rose by over 25,000 in July and cases doubled in 19 states during the month, according to a Reuters tally, dealing a crushing blow to hopes of quickly reopening the economy.

California reported a record increase of more than 11,800 new cases of Covid-19, according to a Reuters tally of county data, as the Trump administration pushes for schools to reopen to help businesses return to normal.

The United States shattered the country’s daily record for coronavirus infections on Thursday, reporting more than 77,000 new cases as the number of deaths in a 24-hour period rose by nearly 1,000, according to a Reuters tally.

California’s governor clamped new restrictions on businesses as coronavirus cases and hospitalizations soared, and the state’s two largest school districts – in Los Angeles and San Diego – said children would be made to stay home in August.

Florida recorded more than 12,600 new coronavirus cases on Monday, its second-highest daily total since the outbreak began, coinciding with the state’s attempt to revive tourism and attract visitors to the recently reopened Disney World.

Florida reported a record increase of more than 15,000 new cases of COVID-19 in 24 hours on Sunday, as the Trump administration renewed a push for schools to reopen and anti-mask protests were planned in Michigan and Missouri.

The U.S. government allocated more than 11,000 courses of Gilead Sciences Inc.’s Covid-19 treatment remdesivir to the four states being hardest hit by the fast-spreading outbreak in the United States.